2025 Annual Meeting | N5 - Neuroscience in the Clinic: Neuromodulation Tools in Stroke Acute Treatment, Prevention, and Recovery

Date Wednesday 04/09/25

Time 01:00 PM - 03:00 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Neuroscience in the Clinic Session

Director(s) Fernando D. Testai, MD, PhD, FAAN, Steven C. Cramer, MD, FAAN

Topic(s) Cerebrovascular Disease and Interventional Neurology

CME Available 2.00 CME credits

Event Timeline
No timeline events available at this time.

Faculty Disclosures
Fernando D. Testai, MD, PhD, FAAN	Dr. Testai has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Testai has received publishing royalties from a publication relating to health care.
Steven C. Cramer, MD, FAAN	Dr. Cramer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Constant Therapeutics, BrainQ, Myomo, MicroTransponder, Panaxium, Beren Therapeutics, Medtronic, Stream Biomedical, NeuroTrauma Sciences, and TRCare. . Dr. Cramer has stock in Constant Therapeutics, Panaxium, and TRCare. The institution of Dr. Cramer has received research support from NIH; PCORI; Veterans Administration.